Joinn Laboratories(China)Co.,Ltd.
603127
Pozycja w akcjach
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Cena akcji
$6.82
Kapitalizacja rynkowa
$4.30B
Zmiana (1 dzień)
-6.30%
Zmiana (1 rok)
184.21%
Kraj
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)
Kategoria
Healthcare
Historia ceny akcji dla Joinn Laboratories(China)Co.,Ltd. (603127)
Najwyższa cena zamknięcia: $3.68 dnia 2026-10-01
Najniższa cena zamknięcia: $6.48 dnia 2021-02-01
Najniższa cena zamknięcia: $6.48 dnia 2021-02-01
Historia cen akcji firmy Joinn Laboratories(China)Co.,Ltd. od 2021 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 11.18% |
| 2025 | 111.15% |
| 2024 | -23.74% |
| 2023 | -55.34% |
| 2022 | -30.77% |
| 2021 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $679.75 | 19.84% |
US
|
|
| $230.41 | 5.65% |
US
|
|
| $398.67 | 112.03% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $172.92 | 18.54% |
US
|
